Racial disparity in clinical course and outcome of metastatic androgen-independent prostate cancer

Urology

Volumn 64, Issue 4, 2004, Pages 738-743

  Thatai, Lata Chandi ^a   Banerjee, Mousumi ^b   Lai, Zongshan ^b   Vaishampayan, Ulka ^a,c  

^a Free University of Brussels   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c Division of Hematology Oncology Department of Internal Medicine 987680 Nebraska Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANDROGEN; LACTATE DEHYDROGENASE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIGEN DETECTION; BONE METASTASIS; CANCER GROWTH; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; DIETARY INTAKE; DISEASE SEVERITY; ENZYME ANALYSIS; EUROPEAN AMERICAN; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RACE DIFFERENCE; REVIEW; SOCIOECONOMICS; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; VISCERAL METASTASIS;

EID: 7444267851     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.05.024     Document Type: Article

References (16)

1. Ries SAG, Kosary CL, Hankey BF,, et al. SEER Report: Racial/Ethnic Patterns of Cancer in the United States 1973-1993. Rockville, MD, National Cancer Institute, 1996.
2. Ries L, Eisner M, and Kosary C: SEER Cancer Statistics Review, 1973-1997. National Institute of Health Publication No. 00-4523. Bethesda, National Cancer Institute, 2000.
3. C.L. Bennett, M.R. Ferreira, T.C. Davis Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer J Clin Oncol 16 1998 3101 3104
4. E.A. Conlisk, E.J. Lengerich, W. Demark-Wahnefried Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina Urology 53 1999 1194 1199
5. L. Harlan, O. Brawley, F. Pommerenke Geographic, age and racial variation in the treatment of local/regional carcinoma of the prostate J Clin Oncol 13 1995 93 9100
6. W. Demark-Wahnefried, T. Strigo, K. Catoe Knowledge, beliefs and prior screening behavior among blacks and whites reporting for prostate cancer screening Urology 46 1995 346 351
7. J.E. Fowler Jr, S.A. Bigler A prospective study of the serum prostate specific antigen concentrations and Gleason histological score of black and white men with prostate carcinoma Cancer 86 1999 836 841
8. P.N. Brawn, E.H. Johnson, D.L. Kuhl Stage at presentation and survival of white and black patients with prostate cancer Cancer 71 1993 2569 2573
9. U. Vaishampayan, M. Glode, D. Crawford Phase II study of dolastatin-10 in patients with hormone refractory metastatic prostate cancer Clin Cancer Res 6 2000 4205 4208
10. U. Vaishampayan, J. Fontana, W. Du An active regimen of weekly paclitaxel and estramustine in metastatic androgen independent prostate cancer Urology 60 2002 1050 1054
11. G.J. Bubley, M. Carducci, W. Dahut Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendation from the Prostate-Specific Antigen Working Group J Clin Oncol 17 1999 3461 3467
12. A.B. Miller, B. Hoogstraten, M. Staquet Reporting results of cancer treatment Cancer 47 1981 207 214
13. P.A. Wingo, S. Bolden, T. Tong Cancer statistics for African Americans CA Cancer J Clin 46 1996 113 125
14. W. Demark-Wahnefried, J.M. Schildkraut, C.E. Iselin Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina Cancer 83 1998 320 330
15. I. Thompson, C. Tangen, A. Tolcher Association of African-American ethnic background with survival in men with metastatic prostate cancer J Natl Cancer Inst 93 2001 219 225
16. O. Smaletz, H.I. Scher, E.J. Small Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration J Clin Oncol 20 2002 3972 3982